Cellular therapy with autologous skeletal myoblasts for ischemic heart disease and heart failure.

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Cardiomyocytes are final differentiated cells that lose the ability to regenerate. Autologous cellular transplantation for cardiac repair has recently emerged as a promising new approach for end-stage heart failure that avoids the risk of immune rejection and ethical problems. Skeletal myoblasts (or satellite cells) are committed progenitor cells located under the basal lamina of adult skeletal muscle; they are committed to multiply after injury. They are highly resistant to ischemia and possess a considerable potential for division in culture. The cardiac milieu might alter the developmental program of grafted myoblast and facilitate their conversion to the slow-twitch phenotype, which is capable of performing cardiac work. We have used autologous cultured myoblast grafts for mouse and rat myocardial infarction in more than 200 cases. From these grafting experiments, it has been shown that cultured autologous myoblast grafting is a useful technique in the treatment of ischemic heart failure. This chapter offers a step-by-step guide to a successful research project on cultured myoblasts for the treatment of myocardial infarction, as well as a set of special techniques for yielding large numbers of skeletal myoblasts and studying postimplantation myocardial repair.

Original languageEnglish (US)
Pages (from-to)193-204
Number of pages12
JournalMethods in molecular medicine
Volume112
StatePublished - Jan 1 2005
Externally publishedYes

Fingerprint

Skeletal Myoblasts
Myoblasts
Myocardial Ischemia
Heart Failure
Myocardial Infarction
Autologous Transplantation
Therapeutics
Basement Membrane
Cardiac Myocytes
Skeletal Muscle
Stem Cells
Ischemia
Transplants
Phenotype
Wounds and Injuries
Research

ASJC Scopus subject areas

  • Molecular Medicine

Cite this

Cellular therapy with autologous skeletal myoblasts for ischemic heart disease and heart failure. / Tang, Yao Liang.

In: Methods in molecular medicine, Vol. 112, 01.01.2005, p. 193-204.

Research output: Contribution to journalReview article

@article{e44d7ce3c0db4f5e8838fa0d97bf70a9,
title = "Cellular therapy with autologous skeletal myoblasts for ischemic heart disease and heart failure.",
abstract = "Cardiomyocytes are final differentiated cells that lose the ability to regenerate. Autologous cellular transplantation for cardiac repair has recently emerged as a promising new approach for end-stage heart failure that avoids the risk of immune rejection and ethical problems. Skeletal myoblasts (or satellite cells) are committed progenitor cells located under the basal lamina of adult skeletal muscle; they are committed to multiply after injury. They are highly resistant to ischemia and possess a considerable potential for division in culture. The cardiac milieu might alter the developmental program of grafted myoblast and facilitate their conversion to the slow-twitch phenotype, which is capable of performing cardiac work. We have used autologous cultured myoblast grafts for mouse and rat myocardial infarction in more than 200 cases. From these grafting experiments, it has been shown that cultured autologous myoblast grafting is a useful technique in the treatment of ischemic heart failure. This chapter offers a step-by-step guide to a successful research project on cultured myoblasts for the treatment of myocardial infarction, as well as a set of special techniques for yielding large numbers of skeletal myoblasts and studying postimplantation myocardial repair.",
author = "Tang, {Yao Liang}",
year = "2005",
month = "1",
day = "1",
language = "English (US)",
volume = "112",
pages = "193--204",
journal = "Methods in molecular medicine.",
issn = "1543-1894",
publisher = "Humana Press",

}

TY - JOUR

T1 - Cellular therapy with autologous skeletal myoblasts for ischemic heart disease and heart failure.

AU - Tang, Yao Liang

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Cardiomyocytes are final differentiated cells that lose the ability to regenerate. Autologous cellular transplantation for cardiac repair has recently emerged as a promising new approach for end-stage heart failure that avoids the risk of immune rejection and ethical problems. Skeletal myoblasts (or satellite cells) are committed progenitor cells located under the basal lamina of adult skeletal muscle; they are committed to multiply after injury. They are highly resistant to ischemia and possess a considerable potential for division in culture. The cardiac milieu might alter the developmental program of grafted myoblast and facilitate their conversion to the slow-twitch phenotype, which is capable of performing cardiac work. We have used autologous cultured myoblast grafts for mouse and rat myocardial infarction in more than 200 cases. From these grafting experiments, it has been shown that cultured autologous myoblast grafting is a useful technique in the treatment of ischemic heart failure. This chapter offers a step-by-step guide to a successful research project on cultured myoblasts for the treatment of myocardial infarction, as well as a set of special techniques for yielding large numbers of skeletal myoblasts and studying postimplantation myocardial repair.

AB - Cardiomyocytes are final differentiated cells that lose the ability to regenerate. Autologous cellular transplantation for cardiac repair has recently emerged as a promising new approach for end-stage heart failure that avoids the risk of immune rejection and ethical problems. Skeletal myoblasts (or satellite cells) are committed progenitor cells located under the basal lamina of adult skeletal muscle; they are committed to multiply after injury. They are highly resistant to ischemia and possess a considerable potential for division in culture. The cardiac milieu might alter the developmental program of grafted myoblast and facilitate their conversion to the slow-twitch phenotype, which is capable of performing cardiac work. We have used autologous cultured myoblast grafts for mouse and rat myocardial infarction in more than 200 cases. From these grafting experiments, it has been shown that cultured autologous myoblast grafting is a useful technique in the treatment of ischemic heart failure. This chapter offers a step-by-step guide to a successful research project on cultured myoblasts for the treatment of myocardial infarction, as well as a set of special techniques for yielding large numbers of skeletal myoblasts and studying postimplantation myocardial repair.

UR - http://www.scopus.com/inward/record.url?scp=23044480519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23044480519&partnerID=8YFLogxK

M3 - Review article

VL - 112

SP - 193

EP - 204

JO - Methods in molecular medicine.

JF - Methods in molecular medicine.

SN - 1543-1894

ER -